Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

No abstract is available for this paper.

• Publication year

  1959

• Venue

  Journal of Clinical Investigation

• Publication date

  1959-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI103905PMID 13673086PMCID PMC442084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of salicylic acid and acetylsalicylic acid on uric acid excretion and plasma uric acid concentration in the normal human subject.

  2009cited by this paper
• Renal tubular secretion of potassium in the normal dog.

  1998cited by this paper
• Zoxazolamine: physiological disposition, uricosuric properties.

  1958cited by this paper
• Non-ionic diffusion and the excretion of weak acids and bases.

  1958cited by this paper
• Electromigration on filter paper of uric acid from serum and synovial fluid.

  1958cited by this paper
• Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents.

  1958influential reference
• Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects.

  1958cited by this paper
• The diagnosis of gout; significance of an elevated serum uric acid value.

  1958cited by this paper
• Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents.

  1958cited by this paper
• Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man.

  1958influential reference
• Value of Uricosuric Agents and in Particular of G.28 315 in Gout

  1958cited by this paper
• A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.

  1957cited by this paper
• Quantitative analysis of uric acid in blood and urine; methods and interpretation.

  1957influential reference
• Evaluation of Uricosuric Agents in Chronic Gout *

  1957cited by this paper
• Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.

  1957cited by this paper
• Effect of Sodium Lactate Infusion on Urate Clearance in Man.∗

  1957cited by this paper
• Effect of Pyrazinamide and Pyrazinoic Acid on Urate Clearance and Other Discrete Renal Functions.∗ †

  1957cited by this paper
• Quantitative analysis of uric acid in blood and urine; methods and interpretation.

  1957cited by this paper
• Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.

  1956cited by this paper
• Inhibition of the uricosuric action of benemid by salicylate.

  1955cited by this paper
• The excretion of salicylate.

  1955cited by this paper
• A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid.

  1955cited by this paper
• Paradoxical Retention of Uric Acid by Uricosuric Drugs in Low Dosage.∗

  1955cited by this paper
• Probenecid and salicylates: the question of interaction in terms of penicillin excretion.

  1955cited by this paper
• The kidney.

  1954cited by this paper
• Sodium Salicylate and Probenecid in the Treatment of Chronic Gout *

  1954cited by this paper
• Ultrafiltrability of Plasma Urate in Man.∗

  1953cited by this paper
• Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.

  1953cited by this paper
• Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.

  1952cited by this paper
• Therapeutic value of probenecid (benemid) in gout.

  1952cited by this paper
• Gout, a derangement of purine metabolism.

  1952cited by this paper
• Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.

  1951cited by this paper
• Some recent advances in the study of uric acid metabolism and gout.

  1951cited by this paper
• The renal mechanism for urate excretion in man.

  1950cited by this paper
• Thiosulphate clearance in pregnancy.

  1950cited by this paper
• The influence of urinary pH on the renal excretion of salicyl derivatives during aspirin therapy.

  1950cited by this paper
• On the Excretion of Salicylic acid in Man: (A Preliminary Report)

  1949cited by this paper
• Renal Tubular Secretion of Potassium in the Normal Dog.∗

  1948cited by this paper
• Factors influencing plasma concentrations of salicylate.

  1948cited by this paper
• The effect of sodium bicarbonate on the renal excretion of salicylate.

  1948cited by this paper
• The Renal Excretion of Potassium.∗

  1948cited by this paper
• Studies on the pharmacology of salicylates.

  1946cited by this paper
• Studies on the pharmacology of salicylates.

  1946cited by this paper
• The metabolism of the methylated purities. 1. The enzymatic determination of urinary uric acid.

  1945cited by this paper
• THE METABOLISM OF THE METHYLATED PURINES II. URIC ACID EXCRETION FOLLOWING THE INGESTION OF CAFFEINE, THEOPHYLLINE, AND THEOBROMINE

  1945cited by this paper
• THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

  1945cited by this paper
• URINARY METABOLITES OF SODIUM SALICYLATE

  1942cited by this paper
• EFFECT OF CARBOHYDRATE AND FAT IN THE DIET ON URIC ACID EXCRETION

  1939cited by this paper
• A STUDY OF THE RETENTION OF URIC ACID DURING FASTING

  1925cited by this paper

• Phytotherapeutic insights into hyperuricemia: a mechanistic and clinical perspective

  2025cites this paper
• Gout

  2025cites this paper
• Optimizing Gout Treatment: A Comprehensive Review of Current and Emerging Uricosurics.

  2024cites this paper
• Managing Gout in Patients with Metabolic Syndrome

  2024cites this paper
• Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review

  2024cites this paper
• History of Treatments Used to Treat Gout and Hyperuricemia

  2023cites this paper
• Tsai-Fan Yu: physician and researcher who established modern gout management

  2023cites this paper
• Hyperthyroidism is an important risk factor for incident gout particularly in younger age groups and males

  2023cites this paper
• Gout Flare and Cardiovascular Events.

  2023cites this paper
• Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications.

  2022cites this paper
• Environmental Triggers of Hyperuricemia and Gout.

  2022cites this paper
• A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications.

  2021cites this paper
• Modulation of Urate Transport by Drugs

  2021cites this paper
• Pathophysiology of Gout.

  2020cites this paper
• Salicylate Toxicity.

  2020cites this paper
• Acute attack of gout precipitated by concomitant use of aspirin and diuretic in a rheumatic mitral stenosis patient

  2019cites this paper
• [Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice].

  2019cites this paper
• Gender impact on the correlations between Graves’ hyperthyroidism and hyperuricemia in Chinese

  2018cites this paper
• Individualized treatment strategies for hyperuricemia informed by a semi‐mechanistic exposure‐response model of uric acid dynamics

  2018cites this paper
• Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options

  2017cites this paper
• Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

  2017cites this paper
• Gouty arthropathy: Review of clinico‐pathologic and imaging features

  2016cites this paper
• Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations

  2016cites this paper
• AND THE ACTIONS OF URICOSURIC DRUGS

  2016cites this paper
• A Clinical and Sonographic Investigation of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricaemia: A Comparison With Normouricaemic Individuals

  2016cites this paper
• Association of Interleukin-23 Receptor (IL-23R) gene variants with Gout and Rheumatic Heart Fever (RHF)

  2015cites this paper
• Population-based study on the epidemiology of gout

  2014cites this paper
• The role of SLC2A9 Variants in Hyperuricemia and Gout

  2014cites this paper
• Population-based Study on the Epidemiology of Gout

  2014cites this paper
• Epidemiology of gout.

  2014cites this paper
• Long-term management of gout: nonpharmacologic and pharmacologic therapies.

  2014cites this paper
• Effects on Uric Acid Metabolism of the Drugs except the Antihyperuricemics

  2014cites this paper
• Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.

  2013cites this paper
• Clinical Aspects of Gout and Associated Disease States

  2013cites this paper
• Uric Acid Metabolism in Humans

  2013cites this paper
• Chronic gout in the elderly

  2013cites this paper
• Low-dose aspirin use and recurrent gout attacks

  2013cites this paper
• Clinical Syndromes of Metabolic Acidosis

  2013cites this paper
• The Effect of Tiaprofenic Acid on Uric Acid Excretion in Man

  2012cites this paper
• Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2

  2012influential citation
• Epidemiology of gout and chondrocalcinosis.

  2012cites this paper
• Simple Analgesics

  2012cites this paper
• 2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia

  2011cites this paper
• Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers

  2011cites this paper
• 2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia

  2011cites this paper
• The 2010 nephrology quiz and questionnaire: part 1.

  2011cites this paper
• PHARMACOLOGY AND DRUG THERAPY

  2011cites this paper
• Risk factors for gout and prevention: a systematic review of the literature

  2011cites this paper
• Gout

  2011cites this paper
• Effect of oral vitamin C supplementation on serum uric acid: A meta‐analysis of randomized controlled trials

  2011cites this paper
• The 2010 Nephrology Quiz and Questionnaire

  2011cites this paper
• Über die Autoren

  2010cites this paper
• NHG-Standaard Jicht

  2009cites this paper
• Assessing the effects of low dose aspirin on uricacid and renal function in healthy adults

  2009cites this paper
• Gouty Arthritis in Acute Cerebrovascular Disease

  2009cites this paper
• Management of hyperuricemia and gout in CKD.

  2008cites this paper
• Venous Catheter for Repeated Haemodialysis in Acute Renal Failure

  2008cites this paper
• IN PRACTICE Management of Hyperuricemia and Gout in CKD

  2008cites this paper
• Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4

  2008cites this paper
• CHAPTER 59 – Clinical Syndromes of Metabolic Acidosis

  2008cites this paper
• Abstracts from 8th International ISSX Meeting

  2007cites this paper
• British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.

  2007cites this paper
• Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis

  2007cites this paper
• Coexisting ankylosing spondylitis and gouty arthritis

  2007cites this paper
• Treatment of crystal arthropathy--history and advances.

  2006cites this paper
• A concise history of gout and hyperuricemia and their treatment

  2006cites this paper
• Renal urate transport.

  2006cites this paper
• Epidemiology, risk factors, and lifestyle modifications for gout

  2006cites this paper
• Case 3: acute gout-risk factors and inappropriate therapy.

  2006cites this paper
• PHYSIOLOGY IN MEDICINE: A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE

  2005cites this paper
• Pathogenesis of Gout

  2005cites this paper
• Urate transport via human PAH transporter hOAT1 and its gene structure.

  2003cites this paper
• Early and late effects of low-dose aspirin on renal function in elderly patients.

  2003cites this paper
• Goutte

  2003cites this paper
• Part 1. Uric acid and losartan

  2002cites this paper
• Effect of Minidose Aspirin on Renal Function and Renal Uric Acid Handling in Healthy Young Adults

  2002cites this paper
• Mini-aspirin: more facets of a tiny pill?

  2002cites this paper
• Nonpharmacologic treatment: avoidance of factors contributing to development of gouty attacks

  2001cites this paper
• Gout: can management be improved?

  2001cites this paper
• The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.

  2000cites this paper
• Mechanism of the uricosuric action of E3040, a drug used to treat inflammatory bowel disease II: Study using DBA/2N mice

  1999cites this paper
• Determination of folate transport pathways in cultured rat proximal tubule cells.

  1998cites this paper
• Allopurinol toxicity after coronary artery bypass grafting

  1998cites this paper
• Drugs Causing Interference with Laboratory Tests

  1996cites this paper
• Gout: The last 50 years

  1996cites this paper
• Uric acid nephrolithiasis: pathogenesis and treatment.

  1992cites this paper
• SALT trial.

  1992cites this paper
• SALT trial.

  1992cites this paper
• Urate Deposition in Man and its Clinical Consequences

  1991cites this paper
• Urate Deposition and Stone Formation in the Kidney in Renal Hypouricemia

  1991cites this paper
• Rheumatic syndromes caused by antirheumatic drugs.

  1991cites this paper
• Drug-induced gout.

  1991cites this paper
• Mechanism of uricosuric action of AA-193 in DBA/2N mice.

  1990cites this paper
• Uric acid metabolism in children.

  1990cites this paper
• Saturable Pharmacokinetics in the Renal Excretion of Drugs

  1989cites this paper
• Interpretation of pharmacologic manipulation of urate transport in man.

  1989cites this paper
• The Activity of AA-193, A New Uricosuric Agent, in Animals

  1989cites this paper
• 25 THE ACTIVITY OF AA-193, A NEW URICOSURIC AGENT, IN ANIMALS

  1988cites this paper
• The association of nephrolithiasis and autosomal dominant polycystic kidney disease.

  1988cites this paper
• Urate metabolism and gout--a perspective.

  1988cites this paper